| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EURPSY.2013.10.005 |
| P8608 | Fatcat ID | release_j2ehbvkex5b4fp5f2ljjjvqaoe |
| P698 | PubMed publication ID | 24321772 |
| P5875 | ResearchGate publication ID | 259252163 |
| P2093 | author name string | W Zhou | |
| C Yang | |||
| N Wang | |||
| J-J Yang | |||
| X-M Li | |||
| Z-Q Zhou | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 419-423 | |
| P577 | publication date | 2013-12-08 | |
| P1433 | published in | European Psychiatry | Q5413047 |
| P1476 | title | Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex | |
| P478 | volume | 29 |
| Q92043421 | (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism |
| Q90406051 | A Review of the Mechanism of Antagonism of N-methyl-D-aspartate Receptor by Ketamine in Treatment-resistant Depression |
| Q33842686 | Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism |
| Q37299377 | Antidepressant-Like Effects of GM1 Ganglioside Involving the BDNF Signaling Cascade in Mice |
| Q104509533 | Antidepressant-relevant behavioral and synaptic molecular effects of long-term fasudil treatment in chronically stressed male rats |
| Q47411156 | Antinociceptive and Anti-Inflammatory Effects of Ketamine and the Relationship to Its Antidepressant Action and GSK3 Inhibition |
| Q39435750 | Behavioral and biochemical effects of ketamine and dextromethorphan relative to its antidepressant-like effects in Swiss Webster mice |
| Q47365024 | Behavioral and biochemical sensitivity to low doses of ketamine: Influence of estrous cycle in C57BL/6 mice |
| Q90427727 | Benefit effect of REM-sleep deprivation on memory impairment induced by intensive exercise in male wistar rats: with respect to hippocampal BDNF and TrkB |
| Q47414662 | Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice. |
| Q64234863 | Both Ketamine and NBQX Attenuate Alcohol-Withdrawal Induced Depression in Male Rats |
| Q64062521 | Challenge and Prospect of Traditional Chinese Medicine in Depression Treatment |
| Q34535259 | Clinical applications of hallucinogens: A review |
| Q34492381 | Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression. |
| Q52667723 | Convergent Mechanisms Underlying Rapid Antidepressant Action. |
| Q64102147 | Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions |
| Q47616820 | Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway |
| Q26765612 | Dendritic Spines in Depression: What We Learned from Animal Models |
| Q36733346 | Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents |
| Q30848010 | Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state |
| Q47625807 | Effect of intraoperative application of ketamine on postoperative depressed mood in patients undergoing elective orthopedic surgery |
| Q61815028 | Effects of subanesthetic intravenous ketamine infusion on neuroplasticity-related proteins in the prefrontal cortex, amygdala, and hippocampus of Sprague-Dawley rats |
| Q35844654 | Effects of the noncompetitive N-methyl-D-aspartate receptor antagonist ketamine on visual signal detection performance in rats |
| Q59138279 | Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors |
| Q98386641 | Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review |
| Q92571861 | Fast-acting antidepressant-like effects of Reelin evaluated in the repeated-corticosterone chronic stress paradigm |
| Q36237851 | Fluoxetine regulates mTOR signalling in a region-dependent manner in depression-like mice |
| Q48472517 | GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine. |
| Q37067121 | Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats |
| Q90464046 | Homeostatic cAMP regulation by the RGS7 complex controls depression-related behaviors |
| Q64943206 | Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of Ketamine's Antidepressant Action. |
| Q41700928 | Identification of a novel, fast-acting GABAergic antidepressant |
| Q39189493 | Identifying fast-onset antidepressants using rodent models |
| Q35748576 | Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons |
| Q36002723 | Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice. |
| Q35606297 | Involvement of the catecholaminergic system on the antidepressant-like effects of Alpinia zerumbet in mice. |
| Q38803371 | KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS. |
| Q55438088 | Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms. |
| Q55089313 | Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide. |
| Q95642618 | Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers |
| Q47380939 | Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling |
| Q90631290 | Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives |
| Q58764387 | Ketamine influences the locus coeruleus norepinephrine network, with a dependency on norepinephrine transporter genotype - a placebo controlled fMRI study |
| Q99615816 | Ketamine normalizes high-gamma power in the anterior cingulate cortex in a rat chronic pain model |
| Q58740675 | Ketamine reduces aversion in rodent pain models by suppressing hyperactivity of the anterior cingulate cortex |
| Q89527723 | Ketamine: The final frontier or another depressing end? |
| Q42257146 | Ketamine: differential neurophysiological dynamics in functional networks in the rat brain |
| Q47658882 | Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine's Antidepressant Response and the Development of Ketamine Addiction |
| Q52580371 | Matrine Exerts Antidepressant-Like Effects on Mice: Role of the Hippocampal PI3K/Akt/mTOR Signaling. |
| Q52658612 | Mechanisms of ketamine action as an antidepressant. |
| Q52600080 | Metabotropic Glutamate Receptor 5 as a Target for the Treatment of Depression and Smoking: Robust Preclinical Data but Inconclusive Clinical Efficacy. |
| Q47869654 | MicroRNA expression profile and functional analysis reveal that miR-206 is a critical novel gene for the expression of BDNF induced by ketamine. |
| Q91864273 | Modified constraint-induced movement therapy alters synaptic plasticity of rat contralateral hippocampus following middle cerebral artery occlusion |
| Q89859733 | Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin |
| Q57293270 | Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants |
| Q91173369 | Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites |
| Q56619553 | Molecular mechanism of noradrenaline during the stress-induced major depressive disorder |
| Q38248776 | Multistage drug effects of ketamine in the treatment of major depression. |
| Q92904770 | N-Methyl-D-aspartate receptor antagonist d-methadone produces rapid, mTORC1-dependent antidepressant effects |
| Q47568734 | Neural basis of major depressive disorder: Beyond monoamine hypothesis |
| Q92512363 | Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function |
| Q38685420 | New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity. |
| Q38650284 | New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs. |
| Q34507177 | New targets for rapid antidepressant action |
| Q95643364 | Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators |
| Q90404969 | Novel rapid-acting antidepressants: molecular and cellular signaling mechanisms |
| Q50119165 | Orphan receptor GPR158 controls stress-induced depression. |
| Q35224315 | PI3K/AKT/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice is involved in the rapid onset antidepressant-like effects of GLYX-13. |
| Q33614178 | Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine |
| Q92873306 | Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective |
| Q26799619 | Remission From Behavioral Dysregulation in a Child With PTSD After Receiving Procedural Ketamine |
| Q92715084 | Revealing brain mechanisms of mTOR-mediated translational regulation: Implications for chronic pain |
| Q38482062 | Role of adult hippocampal neurogenesis in cognition in physiology and disease: pharmacological targets and biomarkers |
| Q36915463 | Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model |
| Q41050258 | S 47445 Produces Antidepressant- and Anxiolytic-Like Effects through Neurogenesis Dependent and Independent Mechanisms. |
| Q47874568 | Single Administration of HBK-15-a Triple 5-HT1A, 5-HT7, and 5-HT3 Receptor Antagonist-Reverses Depressive-Like Behaviors in Mouse Model of Depression Induced by Corticosterone. |
| Q47151084 | Subanesthetic ketamine decreases the incentive-motivational value of reward-related cues |
| Q33604879 | Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants |
| Q36064483 | Tetramethylpyrazine Produces Antidepressant-Like Effects in Mice Through Promotion of BDNF Signaling Pathway |
| Q92219710 | The Effect of Glutamatergic Modulators on Extracellular Glutamate: How Does this Information Contribute to the Discovery of Novel Antidepressants? |
| Q33741366 | The Evidence for Altered BDNF Expression in the Brain of Rats Reared or Housed in Social Isolation: A Systematic Review |
| Q90080179 | The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression |
| Q37249086 | The interactive effects of ketamine and magnesium upon depressive-like pathology |
| Q41630586 | The modulation of NMDA receptors and L-arginine/nitric oxide pathway is implicated in the anti-immobility effect of creatine in the tail suspension test. |
| Q89460856 | The role of glutamatergic modulation in the mechanism of action of ketamine, a prototype rapid-acting antidepressant drug |
| Q54118164 | Total Saikosaponins of Bupleurum yinchowense reduces depressive, anxiety-like behavior and increases synaptic proteins expression in chronic corticosterine-treated mice. |
Search more.